Worthington Steel Board Director Sells 2,500 Shares
A Worthington Steel board director recently sold 2,500 shares as the company pursues a major acquisition. Learn what ...
When Should You Start To Plan For Your Retirement
It's never too early to think about retirement. Learn when to start planning for your retirement and ensure financial stability.
26,408 articles
This Wealth Manager Just Bet on CORO ETF Strategy
A standout move in the world of investing: a wealth manager makes a sizable bet on an active international rotation E...
Luigi Mangione’s Lawyers Back-To-Back Trials Challenge
Lawyers for Luigi Mangione ask a federal judge to delay the federal murder trial and move the state case to September...
AI Company CEO Bets Big on Stock: A Once-In-Generation Move
When a CEO puts real money behind his own company’s stock, investors sit up and take notice. This article breaks down...
AI IPO Frenzy Sparks a Pressure Cooker Ready Market
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
U.S. Says Iran Will Sign a Narrow Nuclear Deal This Week
Deals eyes turn to a potential pact between the U.S. and Iran over Tehran's nuclear program, with a signing anticipat...
Amazon's Prime Coming: Here's What It Means for Stocks
When Prime Day arrives, it isn’t just shoppers who notice. This guide explains how amazon's prime coming. here's move...
Altman Called OpenAI Valuation: Is a $1T IPO Possible
Tech founder moves set a high bar for OpenAI's IPO. This article breaks down the reality behind altman called openai ...
E.L.F. Beauty Shares Down: Two Key Reasons for the Drop
e.l.f. beauty shares down have caught the attention of investors as momentum slows and margins feel pressure. This ar...
Goldman Sachs Vice Chair Warns on Senior Blind Spots
A Goldman Sachs vice chair warns that as leaders rise, supervision fades and blind spots grow. The piece explores the...
Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Percent Owners Sell Million: Inside V2X Insider Moves
Five insiders each owning at least 10% recently sold shares of V2X, Inc., totaling 2.55 million shares for about $173...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status